Literature DB >> 8559804

Frequency of aggregation substance and cytolysin genes among enterococcal endocarditis isolates.

M M Huycke1, M S Gilmore.   

Abstract

Enterococcus faecalis blood isolates were probed for the serine protease activator of cytolysin (cylA) and aggregation substance (asa1), traits that generally reside on pheromone-responsive plasmids, to determine how commonly these genotypes were associated with disease. In dot blot assays, no significant difference was found in the frequency of asa1 for blood isolates [55 of 103 (54%)] and isolates recovered from stool [9 of 14 (60%); P > 0.1, chi 2 test]. In contrast, cylA occurred more frequently among bacteremia isolates [34 of 68 (50%)] than endocarditis [4 of 35 (11%)] or stool isolates (0 of 14; P < 0.001; chi 2 test). However, when the clonality of isolates was accounted for, the frequency of asa1 and cylA among unrelated strains was not significantly different among the three sets of strains (P > 0.2, chi 2 test). The lack of enrichment for asa1 or cylA among clonally unrelated E. faecalis bloodstream isolates fails to support a role for plasmid-encoded aggregation substance or cytolysin in the transition from bacteremia to endocarditis. Clonally related, cytolytic strains, however, demonstrated an increased propensity to cause bloodstream infection.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8559804     DOI: 10.1006/plas.1995.9992

Source DB:  PubMed          Journal:  Plasmid        ISSN: 0147-619X            Impact factor:   3.466


  15 in total

1.  Identification of aerobically and anaerobically induced genes in Enterococcus faecalis by random arbitrarily primed PCR.

Authors:  B D Shepard; M S Gilmore
Journal:  Appl Environ Microbiol       Date:  1999-04       Impact factor: 4.792

2.  Tales of conjugation and sex pheromones: A plasmid and enterococcal odyssey.

Authors:  Don B Clewell
Journal:  Mob Genet Elements       Date:  2011-05

3.  Infection-derived Enterococcus faecalis strains are enriched in esp, a gene encoding a novel surface protein.

Authors:  V Shankar; A S Baghdayan; M M Huycke; G Lindahl; M S Gilmore
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

4.  Bac 32, a novel bacteriocin widely disseminated among clinical isolates of Enterococcus faecium.

Authors:  Takako Inoue; Haruyoshi Tomita; Yasuyoshi Ike
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

5.  Comparative genomic hybridization analysis of Enterococcus faecalis: identification of genes absent from food strains.

Authors:  E Lepage; S Brinster; C Caron; Céline Ducroix-Crepy; L Rigottier-Gois; G Dunny; C Hennequet-Antier; P Serror
Journal:  J Bacteriol       Date:  2006-10       Impact factor: 3.490

6.  Inducible expression of Enterococcus faecalis aggregation substance surface protein facilitates bacterial internalization by cultured enterocytes.

Authors:  C L Wells; E A Moore; J A Hoag; H Hirt; G M Dunny; S L Erlandsen
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

Review 7.  Virulence Plasmids of Nonsporulating Gram-Positive Pathogens.

Authors:  Daria Van Tyne; Michael S Gilmore
Journal:  Microbiol Spectr       Date:  2014-10

8.  Intravenous mouse infection model for studying the pathology of Enterococcus faecalis infections.

Authors:  Claudia Gentry-Weeks; Monica Estay; Cindy Loui; Dale Baker
Journal:  Infect Immun       Date:  2003-03       Impact factor: 3.441

9.  Molecular epidemiology of Staphylococcus aureus and Enterococcus faecalis in endophthalmitis.

Authors:  M C Booth; K L Hatter; D Miller; J Davis; R Kowalski; D W Parke; J Chodosh; B D Jett; M C Callegan; R Penland; M S Gilmore
Journal:  Infect Immun       Date:  1998-01       Impact factor: 3.441

10.  Comparative study using type strains and clinical and food isolates to examine hemolytic activity and occurrence of the cyl operon in enterococci.

Authors:  Teresa Semedo; Margarida Almeida Santos; Paula Martins; Maria Fátima Silva Lopes; José J Figueiredo Marques; Rogério Tenreiro; Maria Teresa Barreto Crespo
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.